159 Pages Premium Report Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 – Pharmacovigilance Industry Overview, Market Segmentation Report, Leaders, Future, Demand, Opportunities, Sales, Company Profiles and Research Insights – Transparency Market Research
Transparency Market Research “Pharmacovigilance Market [Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers (In-House and Contract Outsourcing] – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,“ the global pharmacovigilance market was valued at USD 2,147.3 million in 2012 and is estimated to reach a market worth USD 5,008.2 million in 2019 at a CAGR of 12.9% from 2013 to 2019.
Browse Global Pharmacovigilance Market Report with Full TOC athttp://www.transparencymarketresearch.com/pharmacovigilance-market.html
Rising regulatory concerns, public safety issues, tough inspection regime coupled with instant need of patient reporting has provided the much needed impetus for the pharmacovigilance market. According to World Health Organization (WHO) the pharmacovigilance is defined as the science and activities involved in the detection, assessment, monitoring and evaluation of adverse events or any drug related problems of the medicinal products. The main objective of pharmacovigilance is the safer administration of medicinal products, which is attained through awareness of precise, timely and relevant clinical safety information of medical products.
The rapid growth of global pharmaceutical industry has resulted in the innovation in the number of medicinal products that can treat, cure and prevent various disorders. Although, the newly developed products have various benefits, these are allied with number of adverse drug events that can range from mild to severe side effects often resulting in disabilities, illness and death. In order to evade this, early detection of the adverse drug reactions in clinical trials and active clinical phase IV or post-marketing surveillance is imperative to identify these adverse events associate with the products. Nowadays, all the pharmaceutical companies are actively involved in the safety assessment and monitoring of medicinal products which are under clinical trials and also for marketed products. Until recently, the scope of the drug safety reporting was restricted to assessment and monitoring of very small number of medicinal products but now it has been extended to various products such as medical devices, traditional medicines, blood products, vaccines, etc.
The guidelines for the appropriate implementation of drug safety reporting services has been formulated by various national and international regulatory authorities such as the World Health Organization (WHO) and United States Food and Drug Administration (USFDA) are aiding in enhancement of the overall PV activities being conducted by the pharmaceutical companies
The global market for pharmacovigilance services is segmented based on type of clinical trial phases, service providers and methods used in drug safety reporting. Based on type of clinical trial phases, the market is categorized in to preclinical studies, phase I, II, III, IV or post-marketing surveillance services market. Among these, the market for clinical trial phase IV drug safety reporting services market accounts for the largest market share of 74.7% in 2012 and was valued to USD 1,604.8 million in the same year .
This market is expected to lead the pharmacovigilance market till 2019 owing to rise in public safety issues coupled with growing regulatory concerns regarding safety of the marketed products. In addition, the market is segmented based on type of service providers by in-house and contract outsourcing services market. Among these, contract outsourcing pharmacovigilance services market accounts for the largest market share of 50.8% in 2012 and is forecast to grow at a healthy growth rate of 15.5% during the forecast period of 2013 to 2019. The contributing factors behind such an assessment include its high cost involvement, quality concerns, requirement of highly qualified professionals and growing regulatory concerns.
Geographically, the North American region constituted the largest market for global pharmacovigilance market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 15.2% from 2013 to 2019. This growth has been attributed to large population base, low healthcare cost and high enrolment rate of patients. In addition, favorable government support, growing pharmaceutical industry would trigger the growth of this market in Asian-Pacific region.
The leading market players include Accenture, Plc, Bristol-Myers Squibb, Covance, Inc., Cognizant Technology Solutions, Icon, Plc.,iGATE Corporation, Novartis International AG, Parexel International Corporation, PRA International, Inc., Pharmaceutical Product Development, Inc. (PPD), Pfizer, Inc., Quintiles Transnational Corporation and Wipro Limited.
The global pharmacovigilance market is segmented as follows:
Global Pharmacovigilance Market, by Segments
Pharmacovigilance MarketType of clinical trial phasesPre-Clinical StudiesPhase IPhase IIPhase IIIPhase IV or Post-marketing SurveillanceType of service providersIn-HouseContract OutsourcingType of methods used in drug safety reportingSpontaneous reportingIntensified ADR reportingTargeted reportingCohort event monitoringEHR monitoring
Global Life Sciences BPO Market, by Geography
North AmericaEuropeAsia-PacificRest of the World (ROW)
Related & Recently Published Reports by Transparency Market Research
Membrane Technology Market in Pharmaceutical, Biopharma and Life Sciences – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2019
Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries. Membrane technology includes membrane applications from laboratory drug research to large scale pharmaceutical manufacturing. Applications of membrane technology in pharmaceutical, life sciences and biopharmaceutical industries include lab-scale DNA and protein separation and analysis, drug screening, cell culturing and examination, and virus removal. Single-use disposable technique for biopharmaceuticals and stringent environmental regulations are some of the key factors driving demand for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries. Strict quality and safety standards in pharmaceutical and biopharmaceutical industries, including Good Manufacturing Practices (GMP), have created a demand for membrane technology in pharmaceutical, biopharma and life sciences industry.
On the other hand, high capital and operational cost impede the growth of the membrane technology market in pharmaceutical, biopharmaceutical and life sciences industries. Membrane fouling is one of the major concerns with membrane technology; it decreases membrane efficiency. Membrane filters need to be replaced or washed every three to four years to remove foulants. However, in the absence of an alternate and more efficient filtration technology, demand for membrane technology in pharmaceutical, biopharmaceutical and life sciences industries is expected to witness healthy growth.
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html